Abstract
Background
Severe obesity is associated with a number of cardiometabolic risk factors. Thyroid-stimulating hormone (TSH) levels are often slightly increased in children with obesity. The clinical significance of the mild elevation in TSH in children with obesity is unclear.
Objective
To examine the association between TSH and lipids in children with severe obesity.
Methods
We performed a retrospective analysis of records of children with severe obesity with simultaneous measurements of TSH and lipids. Children with TSH <0.3 mIU/L and ≥10 mIU/L were excluded. The relationship between TSH and lipids was evaluated using univariate/multiple variable linear and logistic regression.
Results
The study included 834 children (age 13.8 ± 4.1 years, males 46%, body mass index [BMI]: 36.9 ± 7.6 kg/m2; BMI z-score 2.6 ± 0.4). Seventy-four (8.9%) children had TSH between 5 and <10 mIU/L (high TSH [HTSH]). TSH was positively associated with non-high-density lipoprotein (HDL) cholesterol (β: 1.74; 95% confidence interval [CI] 0.29–3.20, p = 0.02). Total cholesterol and non-HDL cholesterol were higher in males with HTSH compared to those with normal TSH (175.5 vs. 163.5 mg/dL, p = 0.02 and 133.7 vs. 121.4 mg/dL, p = 0.02, respectively). The odds of elevated non-HDL cholesterol (≥145 mg/dL) was higher in males with HTSH relative to those with normal TSH (odds ratio [OR]: 2.78; 95% CI 1.35–5.69, p = 0.005).
Conclusions
TSH levels were positively associated with non-HDL cholesterol in children with severe obesity. Males with mildly elevated TSH had higher total cholesterol and non-HDL cholesterol compared to males with normal TSH. Further studies are warranted to determine if levothyroxine therapy would result in improvement in total cholesterol or non-HDL cholesterol in children with severe obesity with mildly elevated TSH.
Acknowledgments
This publication was made possible by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), Mayo Clinic Center for Clinical and Translational Science (CCaTS).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766–81.10.1016/S0140-6736(14)60460-8Search in Google Scholar
2. Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of obesity and severe obesity in US children, 1999–2016. Pediatrics 2018;141:e20173459.10.1542/9781610022781-prevalenceSearch in Google Scholar
3. Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation 2013;128:1689–712.10.1161/CIR.0b013e3182a5cfb3Search in Google Scholar PubMed
4. Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med 2015;373:1307–17.10.1056/NEJMoa1502821Search in Google Scholar PubMed
5. Corica D, Aversa T, Valenzise M, Messina MF, Alibrandi A, et al. Does family history of obesity, cardiovascular, and metabolic diseases influence onset and severity of childhood obesity? Front Endocrinol (Lausanne) 2018;9:187.10.3389/fendo.2018.00187Search in Google Scholar PubMed PubMed Central
6. Ayer J, Charakida M, Deanfield JE, Celermajer DS. Lifetime risk: childhood obesity and cardiovascular risk. Eur Heart J 2015;36:1371–6.10.1093/eurheartj/ehv089Search in Google Scholar PubMed
7. Twig G, Yaniv G, Levine H, Leiba A, Goldberger N, et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med 2016;374:2430–40.10.1056/NEJMoa1503840Search in Google Scholar PubMed
8. Srinivasan SR, Frontini MG, Xu J, Berenson GS. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa Heart Study. Pediatrics 2006;118:201–6.10.1542/peds.2005-1856Search in Google Scholar PubMed
9. Berenson GS, Srinivasan SR, Bao W, Newman 3rd WP, Tracy RE, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650–6.10.1056/NEJM199806043382302Search in Google Scholar PubMed
10. McGill HC, Jr., McMahan CA, Zieske AW, Sloop GD, Walcott JV, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000;20:1998–2004.10.1161/01.ATV.20.8.1998Search in Google Scholar
11. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med 2007;357:2371–9.10.1056/NEJMsa073166Search in Google Scholar PubMed
12. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008;29:76–131.10.1210/er.2006-0043Search in Google Scholar PubMed
13. Arrigo T, Wasniewska M, Crisafulli G, Lombardo F, Messina MF, et al. Subclinical hypothyroidism: the state of the art. J Endocrinol Invest 2008;31:79–84.10.1007/BF03345571Search in Google Scholar PubMed
14. Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002;87:1533–8.10.1210/jcem.87.4.8378Search in Google Scholar PubMed
15. Moon S, Kong SH, Choi HS, Hwangbo Y, Lee MK, et al. Relation of subclinical hypothyroidism is associated with cardiovascular events and all-cause mortality in adults with high cardiovascular risk. Am J Cardiol 2018;122:571–7.10.1016/j.amjcard.2018.03.371Search in Google Scholar PubMed
16. Tseng FY, Lin WY, Lin CC, Lee LT, Li TC, et al. Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. J Am Coll Cardiol 2012;60:730–7.10.1016/j.jacc.2012.03.047Search in Google Scholar PubMed
17. Cerbone M, Bravaccio C, Capalbo D, Polizzi M, Wasniewska M, et al. Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol 2011;164:591–7.10.1530/EJE-10-0979Search in Google Scholar PubMed
18. Wasniewska M, Corrias A, Aversa T, Valenzise M, Mussa A, et al. Comparative evaluation of therapy with L-thyroxine versus no treatment in children with idiopathic and mild subclinical hypothyroidism. Horm Res Paediatr 2012;77:376–81.10.1159/000339156Search in Google Scholar PubMed
19. Salerno M, Capalbo D, Cerbone M, De Luca F. Subclinical hypothyroidism in childhood – current knowledge and open issues. Nat Rev Endocrinol 2016;12:734–46.10.1038/nrendo.2016.100Search in Google Scholar PubMed
20. Catli G, Anik A, Unver Tuhan H, Bober E, Abaci A. The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol 2014;6:238–44.10.4274/jcrpe.1594Search in Google Scholar PubMed PubMed Central
21. Catli G, Abaci A, Buyukgebiz A, Bober E. Subclinical hypothyroidism in childhood and adolescense. J Pediatr Endocrinol Metab 2014;27:1049–57.10.1515/jpem-2014-0089Search in Google Scholar PubMed
22. Reinehr T. Thyroid function in the nutritionally obese child and adolescent. Curr Opin Pediatr 2011;23:415–20.10.1097/MOP.0b013e328344c393Search in Google Scholar PubMed
23. Reinehr T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 2006;91:3088–91.10.1210/jc.2006-0095Search in Google Scholar PubMed
24. Rotondi M, Leporati P, La Manna A, Pirali B, Mondello T, et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol 2009;160:403–8.10.1530/EJE-08-0734Search in Google Scholar PubMed
25. Chen H, Zhang H, Tang W, Xi Q, Liu X, et al. Thyroid function and morphology in overweight and obese children and adolescents in a Chinese population. J Pediatr Endocrinol Metab 2013;26:489–96.10.1515/jpem-2012-0299Search in Google Scholar PubMed
26. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, et al. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 2001;107:111–20.10.1172/JCI10741Search in Google Scholar PubMed PubMed Central
27. Burman KD, Latham KR, Djuh YY, Smallridge RC, Tseng YC, et al. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. J Clin Endocrinol Metab 1980;51:106–16.10.1210/jcem-51-1-106Search in Google Scholar PubMed
28. Fontenelle LC, Feitosa MM, Severo JS, Freitas TE, Morais JB, et al. Thyroid function in human obesity: underlying mechanisms. Horm Metab Res 2016;48:787–94.10.1055/s-0042-121421Search in Google Scholar PubMed
29. Pacifico L, Anania C, Ferraro F, Andreoli GM, Chiesa C. Thyroid function in childhood obesity and metabolic comorbidity. Clin Chim Acta 2012;413:396–405.10.1016/j.cca.2011.11.013Search in Google Scholar PubMed
30. Grandone A, Santoro N, Coppola F, Calabro P, Perrone L, et al. Thyroid function derangement and childhood obesity: an Italian experience. BMC Endocr Disord 2010;10:8.10.1186/1472-6823-10-8Search in Google Scholar PubMed PubMed Central
31. Aeberli I, Jung A, Murer SB, Wildhaber J, Wildhaber-Brooks J, et al. During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. J Clin Endocrinol Metab 2010;95:5412–8.10.1210/jc.2010-1169Search in Google Scholar PubMed
32. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002;246:1–190.Search in Google Scholar
33. Skinner AC, Perrin EM, Skelton JA. Prevalence of obesity and severe obesity in US children, 1999–2014. Obesity (Silver Spring) 2016;24:1116–23.10.1002/oby.21497Search in Google Scholar PubMed
34. Expert Panel on Integrated Guidelines for Cardiovascular H, Risk Reduction in C, Adolescents, National Heart L, Blood I. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011;128(Suppl 5):S213–56.10.1542/peds.2009-2107CSearch in Google Scholar PubMed PubMed Central
35. Witte T, Ittermann T, Thamm M, Riblet NB, Volzke H. Association between serum thyroid-stimulating hormone levels and serum lipids in children and adolescents: a population-based study of German youth. J Clin Endocrinol Metab 2015;100:2090–7.10.1210/jc.2014-4466Search in Google Scholar PubMed
36. Radhakishun NN, van Vliet M, von Rosenstiel IA, Weijer O, Beijnen JH, et al. Increasing thyroid-stimulating hormone is associated with impaired glucose metabolism in euthyroid obese children and adolescents. J Pediatr Endocrinol Metab 2013;26:531–7.10.1515/jpem-2012-0302Search in Google Scholar PubMed
37. Lundback V, Ekbom K, Hagman E, Dahlman I, Marcus C. Thyroid-stimulating hormone, degree of obesity, and metabolic risk markers in a cohort of Swedish children with obesity. Horm Res Paediatr 2017;88:140–6.10.1159/000475993Search in Google Scholar PubMed
38. Shalitin S, Yackobovitch-Gavan M, Phillip M. Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters. Horm Res 2009;71:155–61.10.1159/000197872Search in Google Scholar PubMed
39. Unuvar T, Anik A, Catli G, Esen I, Abaci A, et al. Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters. J Endocrinol Invest 2014;37:799–804.10.1007/s40618-014-0100-ySearch in Google Scholar PubMed
40. Radetti G, Grugni G, Lupi F, Marazzi N, Longhi S, et al. The relationship between hyperthyrotropinemia and metabolic and cardiovascular risk factors in a large group of overweight and obese children and adolescents. J Endocrinol Invest 2017;40:1311–9.10.1007/s40618-017-0705-zSearch in Google Scholar PubMed
41. Sert A, Pirgon O, Aypar E, Yilmaz H, Odabas D. Subclinical Hhypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease. Pediatr Cardiol 2013;34:1166–74.10.1007/s00246-013-0638-zSearch in Google Scholar PubMed
42. Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, et al. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005;28:1916–21.10.2337/diacare.28.8.1916Search in Google Scholar PubMed
43. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 2004;89:3365–70.10.1210/jc.2003-031089Search in Google Scholar PubMed
44. Minami Y, Takaya R, Takitani K, Ishiro M, Okasora K, et al. Association of thyroid hormones with obesity and metabolic syndrome in Japanese children. J Clin Biochem Nutr 2015;57:121–8.10.3164/jcbn.15-24Search in Google Scholar PubMed PubMed Central
45. Tognini S, Polini A, Pasqualetti G, Ursino S, Caraccio N, et al. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study. Thyroid 2012;22:1096–103.10.1089/thy.2012.0013Search in Google Scholar PubMed
46. Meng Z, Liu M, Zhang Q, Liu L, Song K, et al. Gender and age impacts on the association between thyroid function and metabolic syndrome in Chinese. Medicine (Baltimore) 2015;94:e2193.10.1097/MD.0000000000002193Search in Google Scholar PubMed PubMed Central
47. Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J Biol Chem 2003;278:34114–8.10.1074/jbc.M305417200Search in Google Scholar PubMed
48. Galman C, Bonde Y, Matasconi M, Angelin B, Rudling M. Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone. Gastroenterology 2008;134:1127–36.10.1053/j.gastro.2008.01.032Search in Google Scholar PubMed
49. Tian L, Song Y, Xing M, Zhang W, Ning G, et al. A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway. Hepatology 2010;52:1401–9.10.1002/hep.23800Search in Google Scholar PubMed
50. Cerbone M, Capalbo D, Wasniewska M, Alfano S, Mattace Raso G, et al. Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism. Eur J Endocrinol 2016;175:11–9.10.1530/EJE-15-0833Search in Google Scholar PubMed
51. Monzani F, Caraccio N, Kozakowa M, Dardano A, Vittone F, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab 2004;89:2099–106.10.1210/jc.2003-031669Search in Google Scholar PubMed
52. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007;92:1715–23.10.1210/jc.2006-1869Search in Google Scholar PubMed
53. Karastergiou K, Fried SK. Cellular mechanisms driving sex differences in adipose tissue biology and body shape in humans and mouse models. Adv Exp Med Biol 2017;1043:29–51.10.1007/978-3-319-70178-3_3Search in Google Scholar PubMed
54. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013;5:1218–40.10.3390/nu5041218Search in Google Scholar PubMed PubMed Central
55. Darling GM, Johns JA, McCloud PI, Davis SR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med 1997;337:595–601.10.1056/NEJM199708283370903Search in Google Scholar PubMed
56. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196–204.10.1056/NEJM199110243251702Search in Google Scholar PubMed
57. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 1991;265:1861–7.10.1001/jama.1991.03460140089033Search in Google Scholar
58. Wasniewska M, Aversa T, Salerno M, Corrias A, Messina MF, et al. Five-year prospective evaluation of thyroid function in girls with subclinical mild hypothyroidism of different etiology. Eur J Endocrinol 2015;173:801–8.10.1530/EJE-15-0484Search in Google Scholar PubMed
59. Aversa T, Valenzise M, Corrias A, Salerno M, De Luca F, et al. Underlying Hashimoto’s thyroiditis negatively affects the evolution of subclinical hypothyroidism in children irrespective of other concomitant risk factors. Thyroid 2015;25:183–7.10.1089/thy.2014.0235Search in Google Scholar PubMed
60. Lazar L, Frumkin RB, Battat E, Lebenthal Y, Phillip M, et al. Natural history of thyroid function tests over 5 years in a large pediatric cohort. J Clin Endocrinol Metab 2009;94: 1678–82.10.1210/jc.2008-2615Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
